CN Stock MarketDetailed Quotes

605116 Aurisco Pharmaceutical

Watchlist
  • 23.39
  • +0.44+1.92%
Market Closed Aug 16 15:00 CST
9.50BMarket Cap29.16P/E (TTM)

Aurisco Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurisco Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.067B--
--2024/FY-- / 1.626B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.067B--
--2024/FY-- / 1.626B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--

Unlock Free Earnings Estimates

Aurisco Pharmaceutical Earnings Reports

  • Announcement of aurisco pharmaceutical's expected performance increase in the first half of 2024.

    Jul 9 12:00 ET

  • Summary of the 2023 Annual Report of Orient Pharmaceutical Co., Ltd.

    Apr 28 12:00 ET

  • Orient Pharmaceutical Co., Ltd. 2023 Annual Report

    Apr 28 12:00 ET

  • Orient Pharmaceutical Co., Ltd. 2024 First Quarter Report

    Apr 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 16, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg